This inventor holds 1 USPTO granted patent. Top assignee: Queen's University at Kingston. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Innovations by Jeremy W Heaton
Introduction
Jeremy W Heaton is an accomplished inventor based in Gananoque, Canada. He has made significant contributions to the field of medicine, particularly in cardiovascular treatments and cancer therapies. His innovative approach combines various therapeutic methods to enhance patient outcomes.
Latest Patents
Jeremy W Heaton holds a patent for a groundbreaking method titled "Combination therapy using sympathetic nervous system antagonists and endothelin antagonists." This patent outlines methods for preventing or inhibiting adverse cardiovascular effects associated with the administration of a sympathetic nervous system antagonist. The methods involve administering both a sympathetic nervous system antagonist and an endothelin antagonist to subjects in need. Additionally, the patent includes methods for treating prostate cancer or benign prostate hyperplasia (BPH) using this combination therapy.
Career Highlights
Heaton's career is marked by his dedication to advancing medical science through innovative research. His work has the potential to improve the efficacy of treatments for various cardiovascular conditions and prostate-related issues. He is affiliated with Queen's University at Kingston, where he continues to contribute to the academic and research community.
Collaborations
Some of his notable coworkers include Michael A Adams and Suzanne K Bridge. Their collaborative efforts have furthered research in the field and have led to significant advancements in therapeutic methods.
Conclusion
Jeremy W Heaton's contributions to medical innovation demonstrate the importance of combining different therapeutic approaches to enhance treatment efficacy. His work continues to impact the field positively, paving the way for future advancements in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
